HLS Therapeutics Inc's total assets for Q1 2025 were $153.95M, a decrease of -3.73% from the previous quarter. TSE:HLS total liabilities were $87.15M for the fiscal quarter, a -1.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.